Previous close | 0.1000 |
Open | 0.1000 |
Bid | 0.0200 |
Ask | 0.0600 |
Strike | 180.00 |
Expiry date | 2024-08-16 |
Day's range | 0.1000 - 0.1000 |
Contract range | N/A |
Volume | |
Open interest | 10 |
JC Parets, founder and chief strategist at All Star Charts, explains why fighting the Dow Breadth is futile and how embracing the approach can simplify your market analysis significantly. He spoke with Yahoo Finance’s Jared Blikre and Sydnee Fried on "Stocks in Translation." Listen to the full episode here, or wherever you get your podcasts. This post was written by Jared Blikre
J&J (JNJ) seeks label expansion for Tremfya for treating moderately to severely active Crohn's disease. This marks the second sBLA filing for Tremfya in three months.
Pfizer, Johnson & Johnson and Eli Lilly are part of the Zacks top Analyst Blog.